Navigation Links
SCARGUARD LABS, LLC Announces Key Consumption Results Fastest Growing Brand and Second in Total Rankings
Date:9/23/2010

GREAT NECK, N.Y., Sept. 23 /PRNewswire/ -- Scarguard Labs, LLC, announced achieving the combined ranking of the #2 branded scar product and the fastest growing scar product in the category according to Information Resources, Inc.'s data ending August 8, 2010.

Scarguard MD dollar sales are up 49.5% over the prior year for the four week period ending August 8, 2010. Scarguard MD is also ranked the #2 branded scar product based on dollar sales for the same four week period.

"We are extremely pleased with the most recent consumption results showing the Scarguard MD brand outpacing all other scar brands in dollar sales growth," said Joel Studin, MD, Chief Executive Officer. This is a result of our 2010 advertising campaign supported by Scarguard's extensive retail distribution and the fact that Scarguard, unlike some of its competitors, actually is effective in helping to prevent scar tissue and reducing old scar tissue.* It is important for the consumer to know which products can really help them improve the way they look, and Scarguard MD has been proven in the medical literature and has now sold more than two million units.

About Scarguard Labs, LLC

Scarguard Labs, LLC is a closely held pharmaceutical company specializing in dermatological medications employing an internationally patented delivery system designed to enhance drug effectiveness utilizing a multi-technology approach. Our flagship product, Scarguard, is the most frequently dispensed product for scars in plastic surgery offices since 2001. In addition, it can be found in most pharmacies, drug distributors, mass merchants, and major grocery chains throughout the United States. Scarguard has multiple topical prescription and non-prescription drugs in the marketplace, or in varying stages of development. For more information, please visit our website at www.scarguard.com.

*Based on independent clinical studies, available by request.


'/>"/>
SOURCE Scarguard Labs, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
2. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
3. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
4. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
5. Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
6. GeoVax Labs, Inc. Provides Clinical Studies Update
7. GeoVax Labs, Inc. Announces Resignation of Director
8. GeoVax Labs, Inc. Announces First Quarter Financial Results
9. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
10. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
11. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):